BGC > Buscar Producto > Glycyl-arginyl-glycyl-aspartyl-seryl-proline | 91037-75-1

Description:
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.

• Molecular Weight:587.58
• Purity:≥95%

Molecular Formula:
C22H37N9O10
Canonical SMILES:
C1CC(N(C1)C(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)CN)C(=O)O
InChI:
InChI=1S/C22H37N9O10/c23-8-15(33)28-11(3-1-5-26-22(24)25)18(37)27-9-16(34)29-12(7-17(35)36)19(38)30-13(10-32)20(39)31-6-2-4-14(31)21(40)41/h11-14,32H,1-10,23H2,(H,27,37)(H,28,33)(H,29,34)(H,30,38)(H,35,36)(H,40,41)(H4,24,25,26)/t11-,12-,13-,14-/m0/s1
InChIKey:
NTEDOEBWPRVVSG-XUXIUFHCSA-N
Solubility:
Soluble in DMSO
Appearance:
White or Off-white Lyophilized Powder
Storage: Store at -20°C
Synonyms:
H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH; glycyl-L-arginyl-glycyl-L-alpha-aspartyl-D-seryl-L-proline